<?xml version="1.0" encoding="UTF-8"?>
<ref id="B101-medicina-57-00217">
 <label>101.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Trieu</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Saund</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Rahate</surname>
    <given-names>P.S.</given-names>
   </name>
   <name>
    <surname>Barge</surname>
    <given-names>V.B.</given-names>
   </name>
   <name>
    <surname>Nalk</surname>
    <given-names>K.S.</given-names>
   </name>
   <name>
    <surname>Windlass</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Uckun</surname>
    <given-names>F.M.</given-names>
   </name>
  </person-group>
  <article-title>Targeting TGF-Î² pathway with COVID-19 drug candidate ARTIVeda/PulmoHeal accelerates recovery from mild-moderate COVID-19</article-title>
  <source>MedRxiv</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1101/2021.01.24.21250418</pub-id>
 </element-citation>
</ref>
